NCT04172285

Brief Summary

Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strangth and performance and increase risk of falls and fractures, physical disability and premature death. Therefore, it is necessary to identify personalized programs of physical activity and supplementation for elderly population in order to improve their physical functions, muscle strengh and body composition. With the present project we aime to assess the effect of a feasible home-based exercise program coupled with food supplementation to improve muscle strength, muscle volume and muscle physical performance potentially associated with sarcopenia in elderly people.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 21, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

2.3 years

First QC Date

November 13, 2019

Last Update Submit

February 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lower limb strength

    Assessed by chair stand test

    Baseline and Week 24

Secondary Outcomes (5)

  • Body composition

    Baseline and Week 24

  • Quantify thigh cross sectional area

    Baseline and Week 24

  • Maximum isometric force that a hand can squeeze

    Baseline and Week 24

  • Maximal Isometric Strength of Knee flexors and extensors

    Baseline AND Week 24

  • Dynamic balance and gait deficits

    Baseline and Week 24

Study Arms (3)

Physical activity group

EXPERIMENTAL
Behavioral: Physical activity

Physical activity and supplementation group

EXPERIMENTAL
Dietary Supplement: Physical activity and supplementation

Control group

EXPERIMENTAL
Other: Control

Interventions

Home-based physical activity program

Physical activity group

Home-based physical activity program and amminoacid supplementation

Physical activity and supplementation group
ControlOTHER

No intervention

Control group

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary lifestyle.
  • Cognitively intact.
  • Autonomous walking.
  • Acceptance of informed consent.

You may not qualify if:

  • Body mass index lower than 18.5 and uppen than 40 kg/m2.
  • History of cancer.
  • Pacemaker user.
  • History of epileptic episodes.
  • Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect movement functions.
  • Bone fractures that influence movement functions.
  • Smoking.
  • Surgical treatments in the prior 6 months.
  • Use of antieptilectics, glucocorticoids, rhGH and testosterone.
  • Hepatic and muscular pathologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, 20141, Italy

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

ExerciseDietary Supplements

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2019

First Posted

November 21, 2019

Study Start

September 18, 2019

Primary Completion

December 20, 2021

Study Completion

December 20, 2021

Last Updated

February 9, 2021

Record last verified: 2021-02

Locations